Arrhythmia Market, By Arrhythmia Type (Atrial Fibrillation, Atrial Flutter, Supraventricular Tachycardia, Ventricular Tachycardia, Ventricular Fibrillation, Bradyarrhythmia, and Premature Contractions (PACs and PVCs)), By Drug Class (Anticoagulants and Antiplatelets (e.g., Warfarin, Apixaban, Aspirin), Class I Sodium Channel Blockers (e.g., Flecainide, Procainamide), Class II Beta Blockers (e.g., Metoprolol, Propranolol), Class III Potassium Channel Blockers (e.g., Amiodarone, Dofetilide), Class IV Calcium Channel Blockers (e.g., Verapamil, Diltiazem), and Others (such as Digitalis Glycosides, etc.)), By Route of Administration (Oral and Parenteral), By Drug Type (Branded and Generic), By Age Group (Pediatric, Adult, and Geriatric), By End User (Hospitals and Cardiac Specialty Clinics, Ambulatory Surgical Centers (ASCs), Diagnostic and Catheterization Labs, Home Healthcare Settings, and Ambulatory Surgical Centers), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)